Alangium Begoniaefolium

Alangium begoniaefolium  (Roxb.) Baill.

1. Taxonomic, Nomenclature & Therapeutic Summary Table

Botanical Attribute Pharmacognostic & Therapeutic Specification
Synonym A. chinense (Lour.) Harms.
Family Alangiaceae.
Habitat The plains and foothills, up to an altitude of 2,100 m.
Ayurvedic Ankola (related sp.).
Folk Akhani.
Action Bark and roots—sedative, anthelmintic.
Taxonomic Cohort Genus Alangium (2 documented species); Family Alangiaceae (2 documented species).

2. Classical Nomenclature, Taxonomy & Biogeographical Context

Alangium begoniaefolium (taxonomically cited with authority (Roxb.) Baill.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Alangiaceae (primary family classification: Alangiaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. In classical and modern botanical literature, the species is cross-referenced under the botanical synonymy A. chinense (Lour.) Harms, which is synchronized to prevent taxonomic ambiguity across regional herbal formularies. Biogeographically, its documented habitat and ecological distribution span: The plains and foothills, up to an altitude of 2,100 m.

Across classical and vernacular Indian systems of medicine, Alangium begoniaefolium is recognized under distinct polyglot nomenclature: in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Ankola (related sp.); in regional Indian folk and vernacular ethnobotany as Akhani. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.

3. Therapeutic Actions, Phytochemistry & Pharmacological Profile

In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Alangium begoniaefolium are: Bark and roots—sedative, anthelmintic. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.

Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Alangium begoniaefolium establish the following evidence base: A triterpenoid was responsible for the sedative effect on motor activity of rat brain. Chloroform extract of the drug, which was devoid of anabasine, exhibited prominent sedative effect in rat. It significantly decreased concentration of norepinephrine in cortex, of dopamine and serotonin (5-HT) in brain stem, but increased concentration of 5-HT in cortex.

4. Comparative Genus & Family Pharmacognosy

Taxonomically, the genus Alangium comprises 2 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Alangium lamarckii (Action: Rootbark—astringent, spasmolytic, hypotensive, also diaphoretic and antipyretic….). Comparing Alangium begoniaefolium alongside its congeners in genus Alangium highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.

At the family level, Alangiaceae encompasses 2 documented medicinal species (0.11% of the 1,814-species flora). Other representative medicinal members of Alangiaceae include: Alangium lamarckii (Ankola). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

image1

Figure 1: Quantitative documentation profile across all 2 medicinal species of family Alangiaceae.

5. Pharmacopoeial Standards, Posology & Reference Framework

In clinical and traditional dispensing, preparation and administration of Alangium begoniaefolium follow the plant-part modalities specified under its therapeutic action (Bark and roots—sedative, anthelmintic), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Alangium begoniaefolium integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.

Scroll to Top